Saltar al contenido
MilliporeSigma
Get up to 22% off for Pi Day until 3/26.Save Now

High-fat diet increased NADPH-oxidase-related oxidative stress and aggravated LPS-induced intestine injury.

Life sciences (2020-03-14)
Shan Wu, Lijie Pan, Haofeng Liao, Weifeng Yao, Ning Shen, Chaojin Chen, Dezhao Liu, Mian Ge
RESUMEN

Lipopolysaccharide (LPS)-induced intestinal injury is a common clinical feature of sepsis. Aggravated inflammation and higher sensitivity to infection are associated with high-fat diet (HFD) in patients with type 2 diabetes and/or obesity. However, the mechanism by which HFD exacerbates LPS-induced intestinal injury has not been elucidated. This study aims to examine the effects of HFD on intestinal injury induced by LPS and the underlying mechanism. Mice were fed with HFD or regular chow for 12weeks and were then challenged with LPS. Vas2870 was administered to mice that received HFD before the initiation of the diet. The levels of tight junction protein expression, oxidative stress, organ injury, and nicotinamide adenine dinucleotide phosphate (NADPH)-associated proteins were assessed periodically. LPS treatment resulted in severe intestinal pathological injury and increased oxidative stress, evidenced by significantly increased serum diamine oxidase, reactive oxygen species, malondialdehyde, and intestinal fatty acid binding protein contents. Additionally, a decrease in tight junction protein expression was observed, indicating a loss of tight junction integrity. LPS treatment induced the expression of Nox2 and Nox4. All the effects were more severe in HFD mice. Treatment with vas2870 conferred protection against LPS-induced intestinal injury in HFD-fed mice, partially reduced oxidative stress, and rescued the expression of tight junction proteins. HFD aggravated LPS-induced intestine injury through exacerbating intestinal Nox-related oxidative stress, which led to a loss of the integrity of tight junctions and consequently increased intestinal permeability.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Human FABP2 / Fatty Acid-Binding Protein, Intestinal ELISA Kit, for serum, plasma, cell culture supernatants and urine
Sigma-Aldrich
VAS2870, ≥97% (HPLC)